Current situation of immuno-oncology development

	Current situation of immuno-oncology development
	Mao Yanyan; Huang Yaoqing; Gao Liubin
刊名	Science & Technology Review
	2017
卷号	35 期号:13 页码:61-65
关键词	anti-tumor immuno-oncology CAR-T cell therapy
ISSN号	1000-7857
其他题名	肿瘤免疫治疗发展现状
文献子类	Article
英文摘要	Cancer is the most serious threat to human health and the most attractive disease in research. With unique advantages in cancer treatment, immuno-oncology is favored by more and more research institutions and pharmaceutical companies, showing a trend of vigorous development in recent years. Due to the complexity of the immune system, cancer immunotherapy covers a variety of action mechanisms and drug forms with different development stages. Based on literature research and database retrieval, the overall situations of development stage, mechanism of action, as well as research institutions of drugs in clinical trials or in market are reported and analyzed in this paper, for depicting the general trend and direction of immunotherapies development and providing references for research and development of antitumor drugs.
资助项目	中国科学院战略性先导科技专项[00000000]
WOS研究方向	Oncology (provided by Clarivate Analytics)
语种	中文
CSCD记录号	CSCD:6030013
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/269199]
专题	信息中心
通讯作者	Mao Yanyan; Gao Liubin
作者单位	Shanghai Institute of Material Medical, Chinese Academy of Sciences, Shanghai 201203, China.
推荐引用方式 GB/T 7714	Mao Yanyan,Huang Yaoqing,Gao Liubin. Current situation of immuno-oncology development[J]. Science & Technology Review,2017,35(13):61-65.
APA	Mao Yanyan,Huang Yaoqing,&Gao Liubin.(2017).Current situation of immuno-oncology development.Science & Technology Review,35(13),61-65.
MLA	Mao Yanyan,et al."Current situation of immuno-oncology development".Science & Technology Review 35.13(2017):61-65.